Richard Anderson
Stock Analyst at Wedbush
(3.53)
# 3,323
Out of 4,955 analysts
140
Total ratings
56.16%
Success rate
3.45%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HR Healthcare Realty Trust | Maintains: Neutral | $18 → $16 | $16.92 | -5.44% | 9 | May 5, 2025 | |
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $22 | $17.28 | +27.31% | 5 | Apr 28, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 | $15.45 | +29.45% | 5 | Apr 1, 2025 | |
| NHI National Health Investors | Reiterates: Outperform | $88 | $77.29 | +13.86% | 4 | Mar 17, 2025 | |
| CTRE CareTrust REIT | Reiterates: Underperform | $26 | $34.54 | -24.72% | 3 | Mar 14, 2025 | |
| STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $11.52 | +21.53% | 2 | Mar 5, 2025 | |
| VTR Ventas | Maintains: Outperform | $69 → $78 | $69.12 | +12.85% | 7 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $166.94 | +0.04% | 5 | Feb 14, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $15.67 | +27.63% | 4 | Jan 13, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $14.79 | +41.99% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $66.42 | +5.39% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $32.96 | +0.12% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $56.75 | +26.87% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $77.41 | +42.10% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $163.78 | +27.61% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $36.53 | +9.50% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $108.02 | +21.27% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $64.27 | +16.70% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $262.76 | +14.55% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $38.56 | +27.07% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $35.58 | +26.48% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $28.43 | +16.07% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $141.01 | +30.49% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $16.15 | +36.22% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $11.17 | +52.19% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $47.39 | +7.62% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $49.55 | -1.11% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $39.06 | +15.21% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $55.36 | +21.03% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.61 | +187.36% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $94.72 | -0.76% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $10.00 | +40.00% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $19.62 | -18.45% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $42.36 | -19.74% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $190.43 | -6.00% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $6.62 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.64 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.97 | - | 2 | Jul 10, 2017 |
Healthcare Realty Trust
May 5, 2025
Maintains: Neutral
Price Target: $18 → $16
Current: $16.92
Upside: -5.44%
Healthpeak Properties
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $22
Current: $17.28
Upside: +27.31%
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.45
Upside: +29.45%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $77.29
Upside: +13.86%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $34.54
Upside: -24.72%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $11.52
Upside: +21.53%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $69.12
Upside: +12.85%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $166.94
Upside: +0.04%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.67
Upside: +27.63%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $14.79
Upside: +41.99%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $66.42
Upside: +5.39%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $32.96
Upside: +0.12%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $56.75
Upside: +26.87%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $77.41
Upside: +42.10%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $163.78
Upside: +27.61%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $36.53
Upside: +9.50%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $108.02
Upside: +21.27%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $64.27
Upside: +16.70%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $262.76
Upside: +14.55%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $38.56
Upside: +27.07%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $35.58
Upside: +26.48%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $28.43
Upside: +16.07%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $141.01
Upside: +30.49%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $16.15
Upside: +36.22%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $11.17
Upside: +52.19%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $47.39
Upside: +7.62%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $49.55
Upside: -1.11%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $39.06
Upside: +15.21%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $55.36
Upside: +21.03%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.61
Upside: +187.36%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $94.72
Upside: -0.76%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $10.00
Upside: +40.00%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $19.62
Upside: -18.45%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $42.36
Upside: -19.74%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $190.43
Upside: -6.00%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $6.62
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $7.64
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $3.97
Upside: -